Merck KGaA presents c-KIT inhibitors with strong antitumor activity in GIST April 26, 2021 No Comments
Discovery and preclinical characterization of novel KRAS G12C inhibitor, LY-3537982 April 21, 2021 No Comments
Revolution Medicines targets SOS-1 with new compound RMC-0331 for RAS-driven cancers April 21, 2021 No Comments
Discovery of EU-129 for treatment of severe COVID-19 in patients with underlying diseases April 19, 2021 No Comments
RSS